ليست عنوان مقالات لاتين Drosophila cohesins DSA1 and Drad21 persist and colocalize along the centromeric heterochromatin during mitosis Dry dispersion of fine particles in gaseous phase

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Drosophila cohesins DSA1 and Drad21 persist and colocalize along the centromeric heterochromatin during mitosis

2

Drosophila cryb mutation reveals two circadian clocks that drive locomotor rhythm and have different responsiveness to light

3

Drosophila CTCF Is Required for Fab-8 Enhancer Blocking Activity in S2 Cells

4

Drosophila Cytokine Unpaired 2 Regulates Physiological Homeostasis by Remotely Controlling Insulin Secretion

5

Drosophila DPM Neurons Form a Delayed and Branch-Specific Memory Trace after Olfactory Classical Conditioning

6

Drosophila Dscam Is an Axon Guidance Receptor Exhibiting Extraordinary Molecular Diversity

7

Drosophila Dumbfounded: A Myoblast Attractant Essential for Fusion

8

Drosophila Enhancer of Zeste/ESC Complexes Have a Histone H3 Methyltransferase Activity that Marks Chromosomal Polycomb Sites

9

Drosophila fasciclinII Is Required for the Formation of Odor Memories and for Normal Sensitivity to Alcohol

10

Drosophila female precopulatory behavior is modulated by ecdysteroids

11

Drosophila Fragile X-Related Gene Regulates the MAP1B Homolog Futsch to Control Synaptic Structure and Function

12

Drosophila Gain-of-Function Mutant RTK Torso Triggers Ectopic Dpp and STAT Signaling

13

Drosophila genome sequence, a model for the human

14

Drosophila Genome-wide Obesity Screen Reveals Hedgehog as a Determinant of Brown versus White Adipose Cell Fate

15

Drosophila gustatory receptors: from gene identification to functional expression

16

Drosophila immunity: paths and patterns

17

Drosophila immunity: two paths to NF-κB

18

Drosophila male courtship behavior is modulated by ecdysteroids

19

Drosophila males transfer antibacterial proteins from their accessory gland and ejaculatory duct to their mates

20

Drosophila melanogaster and D. simulans rescue strains produce fit offspring, despite divergent centromerespecific histone alleles

21

Drosophila melanogaster as a Model to Study Human Neurodegenerative Diseases

22

Drosophila melanogaster Laboratory Rearing for Wolbachia-Based Control Programs, a Component of Dengue Control

23

Drosophila melanogaster males increase the number of sperm in their ejaculate when perceiving rival males

24

Drosophila melanogaster Methoprene-tolerant (Met) gene homologs from three mosquito species: Members of PAS transcriptional factor family

25

Drosophila melanogaster syncytial nuclear divisions are patterned: time-lapse images, hypothesis and computational evidence

26

Drosophila microRNAs Are Sorted into Functionally Distinct Argonaute Complexes after Production by Dicer-1

27

Drosophila model increases understanding of fragile-X syndrome

28

Drosophila Myc Regulates Organ Size by Inducing Cell Competition

29

Drosophila neural progenitor polarity and asymmetric division

30

Drosophila Neuroblasts Sequentially Express Transcription Factors which Specify the Temporal Identity of Their Neuronal Progeny

31

Drosophila p53 Binds a Damage Response Element at the reaper Locus

32

Drosophila p53 Is a Structural and Functional Homolog of the Tumor Suppressor p53

33

Drosophila PAR-1 and 14-3-3 Inhibit Bazooka/PAR-3 to Establish Complementary Cortical Domains in Polarized Cells

34

Drosophila Proteasome Regulator REGγ: Transcriptional Activation by DNA Replication-related Factor DREF and Evidence for a Role in Cell Cycle Progression

35

Drosophila Replication and Repair Proteins: Proliferating Cell Nuclear Antigen (PCNA)

36

Drosophila Rho-Associated Kinase (Drok) Links Frizzled-Mediated Planar Cell Polarity Signaling to the Actin Cytoskeleton

37

Drosophila Rhomboid-1 Defines a Family of Putative Intramembrane Serine Proteases

38

Drosophila serpin 27A is a likely target for immune suppression of the blood cell-mediated melanotic encapsulation response

39

Drosophila Sir2 Is Required for Heterochromatic Silencing and by Euchromatic Hairy/E(Spl) bHLH Repressors in Segmentation and Sex Determination

40

Drosophila song as a species-specific mating signal and the behavioural importance of Kyriacou & Hall cycles in D. melanogaster song

41

Drosophila still flying high in cancer research

42

Drosophila Tsc1 Functions with Tsc2 to Antagonize Insulin Signaling in Regulating Cell Growth, Cell Proliferation, and Organ Size

43

Drosophila Tufted Is a Gain-of-Function Allele of the Proneural Gene amos

44

Drosophila wingless and Pair-Rule Transcripts Localize Apically by Dynein-Mediated Transport of RNA Particles

45

Drosophila Zinc Finger Protein CG9890 Is Colocalized with Chromatin Modifying and Remodeling Complexes on Gene Promoters and Involved in Transcription Regulation

46

Dross formation during remelting of aluminum 5182 remelt secondary ingot (RSI)

47

Dross formation during remelting of aluminum 5182 remelt secondary ingot (RSI)

48

Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial

49

Drought 2002 in Colorado: An Unprecedented Drought or a Routine Drought?

50

Drought acclimation and lipid composition in Folsomia candida: implications for cold shock, heat shock and acute desiccation stress

51

Drought acclimation confers cold tolerance in the soil collembolan Folsomia candida

52

Drought adaptations in wild barley (Hordeum spontaneum) grown in Iran

53

Drought affects the fluxes of carbon to roots and soil in 13C pulse-labelled plants of wheat

54

Drought affects the fluxes of carbon to roots and soil in 13C pulse-labelled plants of wheat

55

Drought Allocations Using the Systems Impact Assessment Model: Klamath River

56

Drought alters respired δ13CO2 from autotrophic, but not heterotrophic soil respiration

57

Drought alters respired δ13CO2 from autotrophic, but not heterotrophic soil respiration

58

Drought analysis in the Lakes of Iran (Case study: Lake Urmia and Gavkhuni Swamp)

59

Drought and Aquatic Ecosystems: Effects and Responses, P. Sam Lake. Wiley-Blackwell, Oxford, Chichester, Hoboken (2011). xiv+381 pp., Price £55.00, Paperback, ISBN: 978-1-4051-8560-8 (also four electronic formats)

60

Drought and climatic change impact on streamflow in small watersheds Original Research Article

61

Drought and clipping effects on tiller demography andgrowth of two tussock grasses in Utah

62

Drought and declining reservoirs: Comparing media discourse in Arizona and New Mexico, 2002–2004

63

Drought and disputes, deluge and dearth: climatic variability and human response in colonial Oaxaca, Mexico

64

Drought and ecosystem carbon cycling

65

Drought and flood signals in subtropical estuaries recorded by stable isotope ratios in bivalve shells

66

Drought and grazing patch dynamics under different grazing management

67

Drought and malaria retreat in the Sahel, West Africa

68

Drought and Salinity Impacts on Bread Wheat in a Hydroponic Culture: A Physiological Comparison

69

Drought and salt tolerance enhancement of transgenic Arabidopsis by overexpression of the vacuolar pyrophosphatase 1 (EVP1) gene from Eucalyptus globulus

70

Drought and saving in West Africa: are livestock a buffer stock?

71

Drought and spring cooling induced recent decrease in vegetation growth in Inner Asia

72

Drought and the Impact of Natural Saline River on the Quality of Surface Water Resources In Karoon River(IRAN)

73

Drought changes the dynamics of trace element accumulation in a Mediterranean Quercus ilex forest

74

Drought class transition analysis through Markov and Loglinear models, an approach to early warning

75

Drought constraints on transpiration and canopy conductance in mature aspen and jack pine stands

76

Drought decreases soil enzyme activity in a Mediterranean Quercus ilex L. forest

77

Drought decreases soil enzyme activity in a Mediterranean Quercus ilex L. forest

78

Drought disturbance from climate change: response of United States forests

79

Drought duration and frequency in the U.S. Corn Belt during the last millennium (AD 992–2004)

80

Drought early warning system in reservoir operation: Theory and practice

81

Drought effects on elongation kinetics and sugar deposition in the elongation zone of durum wheat (Triticum durum Desf.) leaves

82

Drought effects on the early development stages of Panicum virgatum L.: Cultivar differences

83

Drought effects on water relations in beech: The contribution of exchangeable water reservoirs

84

DROUGHT EFFECTS ON YIELD TRAITS OF SOME SUNFLOWER INBRED LINES

85

Drought evolution at various time scales in the lowland regions and their impact on vegetable crops in the Czech Republic

86

Drought experiments within the Solling roof project

87

Drought Flow from Hillslope

88

Drought Flow from Hillslope

89

Drought forecasting based on the remote sensing data using ARIMA models

90

Drought forecasting using feed-forward recursive neural network

91

Drought forecasting using feed-forward recursive neural network

92

Drought forecasting using the Standardized Precipitation Index

93

Drought frequency analysis using cluster analysis and bivariate probability distribution

94

Drought identification and characterization in Jordan

95

Drought impacts on the water quality of freshwater systems; review and integration

96

Drought in groundwater—drought distribution and performance indicators

97

Drought induced pulses of image from a Canadian shield wetland: use of δ34S and δ18O in image to determine sources of sulfur

98

Drought is a major yield loss factor for rainfed East African highland banana

99

Drought mitigation using operative indicators in complex water systems

100

Drought modeling – A review

101

Drought Monitoring and Corn Yield Estimation in Southern Africa from AVHRR Data

102

Drought Monitoring and Prediction using K-Nearest Neighbor Algorithm

103

Drought Monitoring Based on the SPI and RDI Indices under Climate Change Scenarios (Case Study: Semi-Arid Areas of West Golestan Province)

104

Drought monitoring in Iran using the perpendicular drought indices

105

Drought Monitoring in Southern Coasts of Iran

106

Drought monitoring using a Soil Wetness Deficit Index (SWDI) derived from MODIS satellite data

107

Drought Monitoring Using Climatic Indices and Geostatistic Technique (Case Study: Hossein Abad Plain, Sarbisheh, Iran)

108

Drought Monitoring Using MODIS Land Surface Temperature and Normalized Difference Vegetation Index Products in Semi-Arid Areas of Iran

109

Drought Monitoring Using Vegetation Indices and MODIS Data (Case Study: Isfahan Province, Iran)

110

Drought Occurrence Pattern in Tigray Region, Northern Ethiopia

111

Drought Occurrence Probabilities and Risks of Dependent Hydrologic Processes

112

Drought planning and water allocation: an assessment of local capacity in Minnesota

113

Drought prediction using the Along Track Scanning Radiometer (ATSR2) on board ERS2 satellite Original Research Article

114

Drought probabilities and return period for annual streamflows series

115

Drought resistance of 2-year-old saplings of Mediterranean forest trees in the field: relations between water relations, hydraulics and productivity

116

Drought response of two bedding plants

117

Drought responses of Arrhenatherum elatius grown in plant assemblages of varying species richness

118

Drought Risk Assessment In Iraq Using Remote Sensing And GIS Techniques

119

Drought Risk Assessment in Western Inner-Mongolia

120

Drought Risk Assessment: A Case Study in Punjab, Pakistan

121

Drought risk management in agricultural sector with an emphasis on the socioeconomic dimension under Fuzzy Logic in the Sistan region

122

Drought Risk Vulnerability Parameters among Wheat

123

Drought Scenario Analysis Using RiverWare: A Case Study in Urumqi River Basin, China

124

Drought signals in tree-ring stable oxygen isotope series of Qilian juniper from the arid northeastern Tibetan Plateau

125

Drought stress and fluctuating asymmetry in Quercus undulata leaves: confounding effects of absolute and relative amounts of stress?

126

Drought Stress Effect on germination and Seedling Growth Indices in 5 Sugar Beet Genotypes

127

Drought stress effect on some phonological traits of advanced lines of bread wheat

128

Drought stress has contrasting effects on antioxidant enzymes activity and phenylpropanoid biosynthesis in Fraxinus ornus leaves: An excess light stress affair?

129

Drought Stress Impact on Some Biochemical and Physiological Traits of 4 Groundcovers (Lolium perenne, Potentilla spp, Trifolium repens and Frankinia spp) with Potential Landscape Usage

130

Drought Stress in Iranian Endemic Savory (Satureja rechingeri): In vivo and In vitro Studies

131

DROUGHT STRESS INCREASES THE EXPRESSION OF WHEAT LEAF RIBULOSE- 1, 5- BISPHOSPHATE CARBOXYLASE/OXYENASE PROTEIN

132

Drought stress tolerance based on selection indices of resistant crops variety

133

Drought stress tolerance of barley (Hordeum vulgare L.) affected by priming with PEG

134

Drought stress, plant water status, and floral trait expression in fireweed, Epilobium angustifolium (Onagraceae)

135

Drought Stress: A Review

136

Drought Stress-Induced Changes at Physiological and Biochemical Levels in Some Common Vetch (Vicia sativa L.) Genotypes

137

Drought stress-induced compositional changes in tolerant transgenic rice and its wild type

138

Drought stress-induced upregulation of components involved in ferredoxin-dependent cyclic electron transfer

139

Drought threatened semi-arid ecosystems in the Inner Asia

140

Drought tolerance associated with vertical stratification of two co-occurring epiphytic bromeliads in a tropical dry forest

141

Drought Tolerance in Cultivated and Wild Barley Genotypes: The Role of Root System Characteristics

142

Drought Tolerance is Associated with Rooting Depth and Stomatal Control of Water Use in Clones of Coffea canephora

143

Drought Tolerance of Selected Eragrostis Species Correlates with Leaf Tensile Properties

144

Drought Tolerance Screening in Thirty Common Wheat (Triticum aestivum L.) Genotypes

145

Drought tolerance through overexpression of monoubiquitin in transgenic tobacco

146

Drought tolerance through over-expression of the expansin gene TaEXPB23 in transgenic tobacco

147

Drought tolerance, phosphorus efficiency and yield characters of upland rice lines

148

DROUGHT TOLERANT WHEAT CULTIVAR (RAJ) FOR RAINFED AREAS OF KPK, PAKISTAN

149

Drought Utilization Management of Surface and Ground Water (Case study: Qaryat-Al-Arab Watershed)

150

Drought variability and its climatic implications

151

Drought variation trends in different subregions of the Chinese Loess Plateau over the past four decades

152

Drought vulnerability assessment: The case of wheat farmers in Western Iran

153

Drought vulnerability drives land-use and land cover changes in the Rift Valley dry lands of Ethiopia

154

Drought year changes in streambank profiles on incised streams in the Sierra Nevada Mountains

155

Drought, Abscisic Acid and Transpiration Rate Effects on the Regulation of PIP Aquaporin Gene Expression and Abundance in Phaseolus vulgaris Plants

156

Drought, but not salinity, determines the apparent effectiveness of halophytes colonized by arbuscular mycorrhizal fungi

157

Drought, floods and water quality: Drivers of a severe hypoxic blackwater event in a major river system (the southern Murray–Darling Basin, Australia)

158

Drought-adaptive mechanisms involved in the escape/tolerance strategies of Arabidopsis Landsberg erecta and Columbia ecotypes and their F1 reciprocal progeny

159

Drought-induced changes and recovery of photosynthesis in two bean cultivars (Phaseolus vulgaris L.)

160

Drought-induced changes in acid phosphatase activities in wheat in relationship with phosphorus

161

Drought-induced chilling tolerance in cucumber involves Drought-induced chilling tolerance in cucumber involves

162

Drought-induced reduction in uptake of recently photosynthesized carbon by springtails and mites in alpine grassland

163

Drought-induced reduction in uptake of recently photosynthesized carbon by springtails and mites in alpine grassland

164

Drought-induced responses of photosynthesis and antioxidant metabolism in higher plants Review Article

165

Drought-induced variations of water relations parameters in Olea europaea

166

Drought-induced weakening of growth–temperature associations in high-elevation Iberian pines

167

Drought-resistant physiological characteristics of four shrub species in arid valley of Minjiang River, China

168

Drought-responsive mechanisms in rice genotypes with contrasting drought tolerance during reproductive stage

169

Droughts and famines: The underlying factors and the causal links among agro-pastoral households in semi-arid Makueni district, Kenya

170

DROUGHTS AND THEIR IMPACT ON THE ALBANIAN TERRITORY

171

Droughts as random events in the Maya lowlands

172

Drought-sensitivity ranking of deciduous tree species based on thermal imaging of forest canopies

173

Drove roads: Keystone structures that promote ant diversity in Mediterranean forest landscapes

174

Drowned coralline algal dominated deposits off Lanai, Hawaii; carbonate accretion and vertical tectonics over the last 30 ka

175

Drowned shelf-edge deltas, barrier islands and related features along the outer continental shelf north of the head of De Soto Canyon, NE Gulf of Mexico

176

Drowning by numbers and itʹs

177

Drowning discontinuities and stratigraphic correlation in platform carbonates. The late Barremian–early Aptian record of southeast France

178

Drowning in information, but thirsty for knowledge

179

Drowning of a nearshore peat-forming environment, Atane Formation (Cretaceous) at Asuk, West Greenland: sedimentology, organic petrography and geochemistry

180

Drowning out the protection racket: partner manipulation or drought can strengthen ant–plant mutualism

181

Drowning out the protection racket: partner manipulation or drought can strengthen ant–plant mutualism

182

Drowning-out crystallisation of sodium sulphate using aqueous two-phase systems

183

Drowning-out crystallization of l-proline: Effect of anti-solvent composition and processing parameters on crystal size and shape

184

Drowsiness Analysis Using Common Spatial Pattern and Extreme Learning Machine Based on Electroencephalogram Signal

185

Drowsiness Detection – A Visual System for Driver Support

186

Drs. Landon and Kahn respond:

187

dRTP and dPTP a complementary nucleotide couple for the Sequence Saturation Mutagenesis (SeSaM) method

188

Drucker–Prager–Cap creep modelling of pebble beds in fusion blankets

189

Drudeʹs model calculation rule on electrical transport in Sb-doped SnO2 thin films, deposited via sol–gel Original Research Article

190

Druen complement component C3a and C5a promote choroidal neovacularization

191

Drug Use Evaluation of Three Widely Prescribed Antibiotics in a

192

Drug absorption and release properties of crosslinked hydrogels based on diepoxy-terminated poly(ethylene glycol)s and aliphatic polyamines — a study on the effect of the gel molecular structure

193

Drug abuse among nurses: A neglected challenge

194

Drug Abuse among University Students of Rafsanjan, Iran

195

Drug abuse and aggression between intimate partners: A meta-analytic review

196

Drug abuse and bipolar disorder: comorbidity or misdiagnosis?

197

Drug abuse in older US adults worries experts

198

Drug Abuse in Prishtina Region

199

Drug Abuse Pattern and High Risk Behaviors among Addicts in Shahroud County of Semnan Province, Northeast Iran in 2009

200

Drug Abuse Research Trend Investigation with Text Mining

201

Drug abuse toll uncovered in Kenya

202

Drug abuse, HIV/AIDS and stigmatisation in a Dai community in Yunnan, China

203

Drug abuse: A significant variable in schizophrenia research

204

Drug Action at the 5-HT(1A) Receptor in Vivo: Autoreceptor and Postsynaptic Receptor Occupancy Examined with PET and [carbon:yl-11C]WAY-100635

205

Drug Action of Ritodrine on the Sarcoplasmic-Reticulum Ca2+-ATPase from Skeletal Muscle

206

Drug actions in preeclampsia: Aspirin, but not magnesium chloride or dihydralazine, differentially inhibits cultured human trophoblast release of thromboxane and prostacyclin without affecting angiotensin II, endothelin-1, or leukotriene B4 secretion

207

DRUG ADDICTION AND HEPATITIS B AND C IN PAKISTAN

208

Drug addiction and HIV infection on rise in Tajikistan

209

Drug addiction and the economic rationalization of gun control

210

Drug addiction and the economic rationalization of gun control

211

Drug Addiction and Vitamin D Supplementation: How to Address a Health Concern in Methadone Treatment?

212

Drug addiction as drive satisfaction ("antidrive") dysfunction

213

Drug Addiction as Risk for Suicide Attempts

214

Drug addiction in Gaza and the illicit trafficking of tramadol

215

Drug addiction: the neurobiology of disrupted self-control

216

Drug administration to poultry

217

Drug adverse events and drop-out risk: A clinical case

218

Drug advertisements and prescribing

219

Drug advertisements and prescribing

220

Drug advertisements in less-developed countries

221

Drug advertisements in medical journals

222

Drug advertisements that go straight to the hippocampus

223

Drug advertising in medical journals

224

Drug advertising in medical journals

225

Drug advertising in medical journals

226

Drug advertising in medical journals

227

Drug advertising in medical journals

228

Drug advertising in medical journals

229

Drug affinity to immobilized target bio-polymers by high-performance liquid chromatography and capillary electrophoresis

230

Drug allergic reactions and distress vulnerability

231

Drug allergies among patients with borderline personality symptomatology

232

233

Drug allergy transmitted by passionate kissing

234

Drug and alcohol abuse: A clinical guide to diagnosis and treatment (4th ed.) : Marc A. Schuckit. New York: Plenum Press, 1995. 371 pp. (xviii), $34.50

235

Drug and Alcohol Education for Consumer Workers and Caregivers: A Pilot Project Assessing Attitudes Toward Persons With Mental Illness and Problematic Substance Use

236

Drug and alcohol use among drivers admitted to a Level-1 trauma center

237

Drug and Alcohol Use in Emergency Medicine Residency: An Impaired Residentʹs Perspective

238

Drug and alcohol use in Spain: consumption habits, attitudes and opinions

239

Drug and cell encapsulation: Alternative delivery options for the treatment of malignant brain tumors

240

Drug and chemical metabolites in clinical toxicology investigations: The importance of ethylene glycol, methanol and cannabinoid metabolite analyses

241

Drug and DNA delivery to mitochondria

242

Drug and DNA delivery to mitochondria

243

Drug and ECT treatment of depression in the elderly, 1996–2001: a literature review

244

Drug and gene delivery to mucosal tissues: the mucus barrier

245

Drug and herbal medicine-induced nephrotoxicity in children; review of the mechanisms

246

Drug Attitude Inventory in Patients with Bipolar Disorder: Psychometric Properties

247

Drug biotransformation by human hepatocytes. In vitro/in vivo metabolism by cells from the same donor

248

DRUG BIT CUTTING TRACE IMAGE COLOURS AND CUTTING FORCE FLUCTUATION RELATION

249

Drug bulletins: independent information for global use

250

Drug Calculation Cards and Medication Errors in the Neonatal Intensive Care Units

251

Drug calculation skills — Are we running scared?

252

Drug Calculations for Nurses: Robert Lapham, Heather Agar, Arnold, 1995, 0-340604-79-4, 250 pages, Price £5.99

253

Drug choices in the treatment of atrial fibrillation

254

Drug classification systems: Applications and characteristics

255

Drug Clearance and Arterial Uptake After Local Perivascular Delivery to the Rat Carotid Artery

256

Drug combinations best in acute asthma attacks

257

Drug combinations for HD tested in Drosophila

258

Drug combinations for malaria: time to ACT?

259

Drug combinations in pain treatment: a review of the published evidence and a method for finding the optimal combination

260

Drug companies can broadcast across Europe

261

Drug companies caught again for fixing worldwide vitamin prices

262

Drug company sued over research trial in Nigeria

263

Drug company trials come under increasing scrutiny

264

Drug comparison and categorizing regarded with human serum albumin

265

Drug complications poorly recorded in medical charts

266

Drug courts for DWI offenders? The effectiveness of two hybrid drug courts on DWI offenders

267

Drug courts: A bridge between criminal justice and health services

268

Drug Craving Terminology among Opiate Dependents;

269

Drug Cravings and Its Relationship With Family Communication Patterns and Resiliency Through the Mediatory Role of Difficulty in Cognitive Emotion Regulation

270

Drug crops threaten Colombian birds

271

272

Drug delivery and tissue engineering applications of biocompatible pectin–chitin/nano CaCO3 composite scaffolds

273

Drug delivery applications of supercritical fluid technology

274

Drug delivery design for intravenous route with integrated physicochemistry, pharmacokinetics and pharmacodynamics: Illustration with the case of taxane therapeutics

275

Drug delivery devices based on macroporous silica spheres

276

Drug Delivery for Brains and Central Nervous System

277

Drug delivery for in vitro fertilization: Rationale, current strategies and challenges

278

Drug delivery from gold and titanium surfaces using self-assembled monolayers

279

Drug delivery from hydrophobic-modified mesoporous silicas: Control via modification level and site-selective modification

280

Drug delivery in degenerative joint disease

281

Drug delivery in degenerative joint disease: Where we are and where to go?

282

Drug delivery investigations of quaternised poly(propylene imine) dendrimer using nimesulide as a model drug

283

Drug Delivery of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) to Target Brain Tumors

284

Drug Delivery Platforms for Vaginal Infection: Biological Barriers, Microbe-Associated Infections, and Delivery

285

Drug delivery property, bactericidal property and cytocompatibility of magnetic mesoporous bioactive glass

286

Drug delivery strategies for photodynamic antimicrobial chemotherapy: From benchtop to clinical practice

287

Drug delivery strategies in the therapy of inflammatory bowel disease

288

Drug delivery strategies to treat age-related macular degeneration

289

Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities

290

Drug delivery system based on cyclodextrin-naproxen inclusion complex incorporated in electrospun polycaprolactone nanofibers

291

Drug delivery systems : Vascant V. Ranade and Mannfred A. Hollinger CRC Press, Boca Raton, Florida, 1995, 364 pp. Dr Lisa Brannon-Peppas

292

Drug delivery systems using sandwich configurations of electrospun poly(lactic acid) nanofiber membranes and ibuprofen

293

Drug delivery systems: polymers and drugs monitored by capillary electromigration methods

294

Drug delivery therapies I: General trends and its importance on bone tissue engineering applications

295

Drug delivery therapies II.: Strategies for delivering bone regenerating factors

296

Drug Delivery through Nose: A Noninvasive Technique for Brain Targeting

297

Drug delivery to mitochondria: the key to mitochondrial medicine

298

Drug delivery to mitochondria: the key to mitochondrial medicine

299

Drug delivery to peroxisomes: Employing unique trafficking mechanisms to target protein therapeutics

300

Drug delivery to solid tumors by elastin-like polypeptides

301

Drug delivery to the brain in Alzheimerʹs disease: Consideration of the blood–brain barrier

302

Drug delivery to the brain-just a sniff away

303

Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?

304

Drug delivery to the posterior segments of the eye

305

Drug delivery vehicles on a nano-engineering perspective

306

Drug Demand Function for Iranian Urban Households Based on Householdsʹ Budget

307

Drug Dependency and Womenʹs Health

308

Drug dependent parents: Childcare responsibilities, involvement with treatment services, and treatment outcomes

309

Drug deregulation in Japan likely by 1998

310

Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase

311

Drug design and synthesis of ε opioid receptor agonist: 17-(cyclopropylmethyl)-4,5α-epoxy-3,6β-dihydroxy-6,14-endoethenomorphinan-7α-(N-methyl-N-phenethyl)carboxamide (TAN-821) inducing antinociception mediated by putative ε opioid receptor Original Resea

312

Drug design with a new transition state analog of the hydrated carbonyl: silicon-based inhibitors of the HIV protease Original Research Article

313

Drug design, synthesis, and evaluation of a non-sugar-based selectin antagonist

314

Drug design; HIV; Organosilane; Protease inhibitor; Silanediol

315

Drug detection based on the conformational changes of calmodulin and the fluorescence of its enhanced green fluorescent protein fusion partner Original Research Article

316

Drug detection by tandem mass spectrometry on the basis of adduct formation

317

Drug development and clinical research in the UK

318

Drug development for neglected diseases

319

Drug development for neglected diseases: a deficient market and a public-health policy failure

320

Drug development for tuberculosis: the missing ingredient

321

Drug development output: what proportion for tropical diseases?

322

Drug diffusion from disperse systems with a hydrophobically modified polysaccharide: Enhancer® vs Franz cells

323

Drug diffusion in hydrophobically modified N,N-dimethylacrylamide hydrogels

324

Drug Diffusion Inside a Non-Degradable Hydrogel Microneedle

325

DRUG DISCONTINUATION IN EPILEPTIC CHILDREN: PREDICTIVE VALUE OF THE EEG

326

Drug Discovery Acceleration Using Digital Microfluidic Biochip Architecture and Computer-aided-design Flow

327

Drug discovery and chemokine receptor antagonists: eppur si muove!

328

Drug Discovery and Delivery in the 21st Century

329

Drug Discovery and Evaluation

330

Drug discovery and sea hares: bigger is better

331

Drug Discovery in the Clouds

332

Drug discovery in the new millennium: the pivotal role of biotechnology

333

Drug discovery in the wake of genomics

334

Drug discovery of the future: the implications of the human genome project

335

Drug discovery through stem cell-based organoid models

336

Drug dispensing systems in Gaza hospitals: a comparative study

337

Drug disposition in obesity and protein-energy malnutrition

338

Drug distribution within poly(ɛ-caprolactone) microspheres and in vitro release

339

Drug dosing errors in simulated paediatric emergencies – Comprehensive dosing guides outperform length-based tapes with precalculated drug doses

340

Drug efficacy of praziquantel and albendazole in school children in Mwea Division, Central Province, Kenya

341

Drug efflux transporters in the CNS

342

Drug elimination in chronic liver diseases

343

Drug eluting stent

344

Drug ELuting Stent Complications

345

Drug eluting stent implantation for the treatment of symptomatic myocardial bridging is associated with favorable peri-procedural results and short-term outcomes

346

Drug Eluting Stent Restenosis

347

Drug eluting stents

348

Drug Eluting Stents Comparisons

349

Drug Eluting Stents I

350

Drug Eluting Stents II

351

Drug Eluting Stents in Diabetic Patients

352

Drug eluting stents may not be the answer for myocardial bridges

353

Drug eluting stents: Comparative results

354

Drug eluting stents: Current status and new developments

355

Drug eluting stents: In stent restenosis

356

Drug eluting stents: Long term results

357

Drug eradicates Chagasʹ parasite in mice

358

Drug evaluations using a novel microphysiometer based on cell-based biosensors

359

Drug excretion in breast milk: mechanisms, models and drug delivery implications for the infant

360

Drug excretion into breast milk—Overview

361

Drug exposed infants in the social welfare system and Juvenile Court

362

Drug firm buys up chain of US cancer clinics

363

Drug firm compensates patients for suspected hepatitis B vaccine failure

364

Drug firm support of American Medical Association ethics effort draws fire

365

Drug firm withdraws statin from the market

366

Drug firms lose patent rights lawsuit against South Africaʹs government

367

Drug firmsʹ representatives express concern over WHOʹs AIDS drug list

368

Drug firms take South Africaʹs government to court

369

Drug firms under fire over anti-competition in USA

370

Drug for impotence breaks prescription records

371

Drug Guru: A computer software program for drug design using medicinal chemistry rules Original Research Article

372

Drug Hypersensitivity Reactions in Hospital-Admitted Children: A Single Center Study in Southern Iran

373

drug hypersensitivity reactions in hospital-admitted children: a single center study in southern iran

374

Drug identification performance on the basis of observable signs and symptoms

375

Drug immunosuppression therapy for adult heart transplantation. Part 1: immune response to allograft and mechanism of action of immunosuppressants

376

Drug immunosuppression therapy for adult heart transplantation. Part 2: clinical applications and results

377

Drug impurity profiling: Method optimization on dissimilar chromatographic systems: Part I: pH optimization of the aqueous phase Original Research Article

378

DRUG INDUCED (CALCIUM CHANNEL BLOCKERS) GINGIVAL HYPERPLASIA

379

Drug Induced Autoimmune Hepatitis by Amoxicillin- Clavulanate

380

Drug induced blistering and the plastic surgeon: a case of amitriptyline induced skin necrosis

381

Drug Induced Ectropion: a Systematic Review

382

Drug Induced Gingival Overgrowth and Its Management

383

Drug induced hepatitis among Iranian patients suffering from tuberculosis

384

Drug Induced Sialorrhea and Microfluidic-Chip-Electrophoretic Analysis of Engorged Adult Female Tick Saliva of Haemaphysalis longicornis (Acari: Ixodidae)

385

Drug Induced Sleep Endoscopy in Obstructive Sleep Apnea

386

Drug industry lobbies against European research-data directive

387

Drug Information Resources at Private Community Pharmacies in Kuwait

388

Drug Injecting and HIV Infection: Global Dimensions and Local Responses; Edited by Gerry Stimson, Don C. Des Jarlais and Andrew Ball. UCL Press Ltd, London, 1998. 294 pp, £14.95 (paper).

389

Drug injection and associated factors among the elderly living with HIV/AIDS in Tehran, Iran

390

Drug injection cessation among HIV-infected injecting drug users

391

Drug interaction between rifampicin and sirolimus in transplant patients

392

Drug Interaction of Glycyrrhiza glabra L. with Chemical Drugs: A mini Review study

393

Drug interaction of St Johnʹs wort with ciclosporin

394

Drug Interactions Among Hospitalized Patients in Intensive Care Units and Infectious Ward, Hamadan, Iran

395

Drug interactions and anti-infective therapies

396

Drug Interactions between Psychoactive Agents and Antiepileptic Agents

397

Drug Interactions Casebook: The Cytochrome P450 System and Beyond, 2nd ed.: By Neil B. Sandson. Washington, DC, American Psychiatric Press, 2003 ($35.50, paperback ed.), 334 pp

398

Drug interactions in cancer patients: A hidden risk?

399

Drug Interactions in Iranian Veterans With Chronic Spinal Cord Injury - A Descriptive Study

400

Drug Interactions of Green Tea

401

Drug Interactions of Medicinal Plants with Chemical Antidiabetic Drugs

402

Drug Interactions of Metformin Involving Drug Transporter Proteins

403

Drug Interactions of Psychiatric and COVID-19 Medications

404

Drug interactions of zonisamide with phenytoin and sodium valproate: serum concentrations and protein binding

405

Drug interactions with potential rubber closure extractables: Identification of thiol–disulfide exchange reaction products of captopril and thiurams

406

Drug interactions with the taxanes: clinical implications

407

Drug interactions with zileuton

408

Drug interactions with zileuton

409

Drug interactions—fact or fiction?

410

Drug intervention trials in sepsis

411

Drug intervention trials in sepsis: divergent results

412

Drug kinetics and drug resistance in optimal chemotherapy

413

Drug Literacy in Iran: the Experience of Using “The Single Item Health Literacy Screening (SILS) Tool”

414

Drug loaded poly[Lac(Glc-Leu)] microparticles: Formulation and release characteristics

415

Drug loaded thermoresponsive and cytocompatible chitosan based hydrogel as a potential wound dressing

416

Drug loading onto ion-exchange microspheres: Modeling study and experimental verification

417

Drug loading, dispersion stability, and therapeutic efficacy in targeted drug delivery with carbon nanotubes Original Research Article

418

Drug Management in Crisis and Disaster in Selected Countries and Iran

419

DRUG MANAGEMENT REVIEWS IN DISTRICT DRUG MANAGEMENT UNIT AND GENERAL HOSPITAL

420

Drug may avoid need for parathyroidectomy

421

Drug Mediated S-glutathionylation of PDI leads to alterations in secondary structure, inhibition of isomerase activity, and triggers ER-stress induced apoptosis

422

Drug metabolism and drug interactions in the elderly

423

Drug metabolism enzymes in a steatotic model of rat treated with a high fat diet and a low dose of streptozotocin

424

Drug name confusion: evaluating the effectiveness of capital (“Tall Man”) letters using eye movement data

425

Drug nanocarrier agents based on starch-g-amino acids

426

Drug Nano-Particles Formation by Supercritical Rapid Expansion Method; Operational Condition Effects Investigation

427

Drug partition chromatography on immobilized porcine intestinal brush border membranes

428

Drug Patents 2001: A Review of Pharmaceutical Patenting, 1995–2001

429

Drug permeation modeling through the thermo-sensitive membranes of poly(N-isopropylacrylamide) brushes grafted onto micro-porous films

430

Drug permeation through temperature-sensitive membranes prepared from poly(vinylidene fluoride) with grafted poly(N-isopropylacrylamide) chains

431

Drug policy in China: pharmaceutical distribution in rural areas

432

Drug policy: should the law take a back seat?

433

Drug prescribing practices of general practitioners and paediatricians for childhood diarrhoea in Karachi, Pakistan

434

Drug prescription habits in public and private health facilities in 2 provinces in South Africa

435

Drug Prescription Pattern in a Nigerian Tertiary Hospital

436

Drug prescriptions after acute myocardial infarction: Dosage, compliance, and persistence

437

Drug prescriptions and referral to cardiac rehabilitation after acute coronary events: comparison between men and women in the French PREVENIR Survey

438

Drug prevents SIV infection

439

Drug pricing policies in one of the largest drug manufacturing nations in the world: Are affordability and access a cause for concern?( Editorial Jan-Mar 2015 / Vol 4 / Issue 1)

440

Drug problem recognition among african american drug-using arrestees

441

Drug Properties, Chemical Reactivity and Docking Binding Energy of Cinnamon with Estrogen, Testosterone, Progesterone as Potential Drug: Theoretical Investigation

442

Drug quality, a contributor to drug resistance?

443

Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Cause Interstitial Nephritis: a case Report and Review of Literatures

444

Drug Rash With Eosinophilia and Systemic Symptoms Syndrome in Infancy: A Report of Two Rare Cases

445

Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification

446

Drug Reaction with Eosinophilia and Systemic Symptom in a Patient with Pneumonia and Hyperthyroidism

447

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Presenting with Primary Diagnosis of Hepatocellular Carcinoma

448

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and Myocarditis: A Case Report and Literature Review on Fatal Complications of Reactivated Viral Infections

449

Drug Reaction With Eosinophilia and Systemic Symptoms Induced by Valproic Acid: A Case Report

450

Drug Reaction With Eosinophilia and Systemic Symptoms Induced by Valproic Acid: A Case Report

451

Drug reaction with eosinophilia and systemic symptoms syndrome associated with Nitrofurantoin

452

Drug Receptor Identification from Multiple Tissues Using Cellular-Derived mRNA Display Libraries Original Research Article

453

Drug Recognition and Stabilisation of the Parallel-stranded DNA Quadruplex d(TTAGGGT)4 Containing the Human Telomeric Repeat

454

Drug referendum backs Swiss government

455

Drug reimportation: sitting in the middle

456

Drug related deaths in Tehran, Iran: Toxicological, Death and Crime Scene investigations

457

Drug related deaths—causes and numbers

458

Drug Related Hospital Admissions; A Systematic Review of the Recent Literatures

459

Drug release behavior of beads and microgranules of chitosan

460

Drug release behavior of chitosan–montmorillonite nanocomposite hydrogels following electrostimulation

461

Drug Release Characteristics and Tissue Distribution of Rifapentine Polylactic Acid Sustained-Release Microspheres in Rabbits after Paravertebral Implantation

462

Drug release characteristics of phase separation pHEMA sponge materials

463

Drug release from a N-vinylpyrrolidinone/acrylic acid lubricious hydrophilic coating

464

Drug release from a porous ion-exchange membrane in vitro

465

Drug release from a two-layer stent coating considering the viscoelastic property of the arterial wall: A mathematical and numerical study

466

Drug release from calcium and zinc pectinate beads: Impact of dissolution medium composition

467

Drug release from chitosan–alginate complex beads reinforced by a naturally occurring cross-linking agent

468

Drug release from ion-exchange microspheres: Mathematical modeling and experimental verification

469

Drug release from layered double hydroxides and from their polylactic acid (PLA) nanocomposites

470

Drug release from starch-acetate microparticles and films with and without incorporated α-amylase

471

Drug release from α,β-poly(N-2-hydroxyethyl)- -aspartamide-based microparticles

472

Drug release kinetics and biological properties of a novel local drugcarrier system

473

Drug release kinetics from monolayer films of glucose-sensitive microgel

474

Drug release mechanisms of chemically cross-linked albumin microparticles: Effect of the matrix erosion

475

Drug release rate and kinetic investigation of composite polymeric nanofibers

476

Drug Release Studies from Caesalpinia pulcherrima Seed Polysaccharide

477

Drug Release Studies of Naproxen Agglomerates Produced by the Antisolvent Approach in the Presence of Hydroxypropyl Cellulose

478

Drug release through liposome pores

479

Drug Repositioning and Pharmacophore Identification in the Discovery of Hookworm MIF Inhibitors Original Research Article

480

Drug Repositioning: A Review

481

Drug Repurposing for Identification of S1P1 Agonists with Potential Application in Multiple Sclerosis Using In Silico Drug Design Approaches

482

Drug Repurposing Is a New Opportunity for Developing Drugsagainst Neuropsychiatric Disorders

483

Drug resistance against 5-fluorouracil and cisplatin in the treatment of head and neck squamous cell carcinoma: A systematic review

484

Drug resistance among acid-fast bacilli

485

Drug resistance among chronic HIV-1-infected patients naïve for use of anti-retroviral therapy in Sao Paulo city

486

Drug resistance and apoptosis-inducing strategies in cancer therapy

487

Drug resistance and influenza pandemics

488

Drug resistance and influenza pandemics

489

Drug resistance and influenza pandemics

490

Drug resistance and influenza pandemics

491

Drug Resistance and Serotyping of Uropathogenic Escherichia coli Among Patients With Urinary Tract Infection in Rasht, Iran

492

Drug resistance and Susceptibility of Mycobacterium tuberculosis identified at University Kebangsaan Malaysia Medical Centre

493

Drug Resistance and the Prevention Strategies in Food Borne Bacteria: An Update Review

494

Drug resistance and virulence-associated genes screening in Salmonella enterica isolated from Caspian pony, Iran

495

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

496

Drug resistance gene transfer: Stem cell protection and therapeutic efficacy

497

Drug resistance in cancer, J.H. Goldie, A.J. Goldman. Cambridge University Press, Cambridge (1998)

498

Drug resistance in epilepsy: not futile, but complex?

499

Drug Resistance in Equine Parasites: An Emerging Global Problem

500

Drug resistance in isolated bacteria from milk of sbeep and goats witb subclinical mastitis in Sbabrekord district

501

Drug resistance in malaria: Its population biology and implications for control

502

Drug Resistance in the Clinical Management of HIV – A Special Focus on the Adherence Issues

503

Drug resistance in tuberculosis—a reinfection model

504

Drug resistance models for malaria

505

Drug Resistance of Acinetobacter in Selected Hospitals

506

Drug resistance of isolated strains of Pseudomonas Aeruginosa from burn wound infections to selected antibiotics and disinfectants

507

DRUG RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS

508

Drug Resistance of Mycobacterium tuberculosis Complex among Newly Diagnosed Tuberculosis Cases in Burkina Faso

509

Drug Resistance of Pseudomonas aeruginosa and Enterobacter cloacae Isolated from ICU, Babol, Northern Iran

510

DRUG RESISTANCE PATTERN AMONG AFB SMEAR POSITIVE RETREATMENT COMPLETED CASES

511

Drug resistance pattern and associated risk factors of tuberculosis patients in the central province of Iran

512

Drug resistance pattern and outcome of treatment in recurrent episodes of tuberculosis

513

Drug Resistance Pattern of Pseudomonas aeruginosa Isolates Carrying MexAB-OprM Efflux Pump’s Associated Genes in Companion Birds with Respiratory Infection

514

Drug resistance pattern of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients at Isfahan AL Zahra hospital, Iran (2009-2010)

515

Drug Resistance Patterns in HIV Patients with Virologic Failure in Iran

516

Drug resistance patterns in pulmonary tuberculosis

517

Drug resistance profile and subtyping of HIV-1 RT gene in Iranian patients under treatment

518

Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells

519

Drug Resistance versus Spiritual Resistance: A Comparative Analysis from the Perspective of Spiritual Health

520

Drug resistance, plasmids, biotypes and susceptibility to bacteriophages of Salmonella isolated from poultry in Canada

521

Drug Resistance: A Periplasmic Ménage à Trois

522

Drug resistance–virulence relationship in Plasmodium falciparum causing severe malaria in an area of seasonal and unstable transmission

523

Drug resistant neuroleptic malignant syndrome and the role of electroconvulsive therapy

524

Drug resistant Plasmodium falciparum in an area of seasonal transmission

525

Drug resistant tuberculosis in Africa: Current status, gaps and opportunities

526

Drug Resistant Tuberculosis: Gold, Glitter and Hope

527

Drug risk assessment with determining the number of sub-populations under finite mixture normal models

528

Drug Safety Crises Management in Pharmacovigilance

529

Drug Screening versus History in detection of substance use in ED Psychiatric Patients

530

531

Drug sensitivity of trypanosome populations from cattle in a peri-urban dairy production system in Uganda

532

Drug sensitivity patterns of bacterial isolates from septic post-operative wounds in a regional referral hospital in Uganda

533

Drug shows potential for treatment of Huntingtonʹs disease

534

Drug shows promise for treatment of Alzheimerʹs disease

535

Drug solubility: how to measure it, how to improve it

536

Drug Stroop performance: Relationships with primary substance of use and treatment outcome in a drug-dependent outpatient sample

537

Drug subsidy could help Tanzania tackle malaria

538

Drug Supply Chain Management and Implementation of Health Reform Plan in Teaching Hospital Pharmacies of Ahvaz, Iran

539

DRUG SUSCEPTIBILITY OF STREPTOCOCCUS PNEUMONIAE STRAINS ISOLATED IN TEHRAN, IRAN

540

Drug Switching, a Creative Approach to Leukemia Therapy

541

Drug target inference through pathway analysis of genomics data

542

Drug targeting of airway surface liquid: A pharmacological MRI approach

543

Drug targeting to choroidal neovascularization

544

Drug targeting to hypoxic tissue using self-inactivating bioreductive delivery systems

545

Drug targeting to the kidney

546

Drug targeting to the kidney: Advances in the active targeting of therapeutics to proximal tubular cells

547

Drug testing litigation: Trends and outcomes

548

Drug testing sworn law enforcement officers: One agencyʹs experience

549

Drug Therapeutic Failures as a Cause of Admission to an Intensive Care Unit at a University Hospital

550

551

552

Drug therapy and microvolt T-wave alternans testing

553

Drug therapy and microvolt T-wave alternans testing

554

Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy

555

Drug therapy for coronary heart disease: the Sheffield table

556

Drug therapy for coronary heart disease: the Sheffield table

557

Drug therapy for coronary heart disease: the Sheffield table

558

Drug therapy for coronary heart disease: the Sheffield table

559

Drug therapy for coronary heart disease: the Sheffield table

560

Drug therapy for coronary heart disease: the Sheffield table

561

Drug Therapy for Hypercholesterolemia in Patients With Cardiovascular Disease: Factors Limiting Achievement of Lipid Goals

562

Drug Therapy for Hypercholesterolemia: Time to End the Double Standard

563

Drug therapy for inflammatory bowel disease in pregnancy and the puerperium

564

Drug therapy for management of obesity

565

Drug therapy for management of obesity

566

Drug Therapy for Small Abdominal Aortic Aneurysm

567

Drug therapy for treatment of obesity

568

Drug therapy for urinary incontinence

569

Drug therapy for vertebral fractures in osteoporosis: Evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy

570

Drug Therapy in Atrial Fibrillation Management: Where Do We Stand in 2010?

571

Drug therapy in paediatric patients

572

Drug therapy in reproductive endocrinology

573

Drug therapy increases long-term survival in pulmonary hypertension patients

574

Drug therapy of diabetes in the elderly

575

Drug therapy versus implantation of a cardiac defibrillator for the treatment of malignant arrhythmias in left ventricular dysfunction

576

Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism

577

Drug Trafficking and Criminal Justice

578

Drug trajectories among youth undergoing treatment: The influence of psychological problems and delinquency

579

Drug transfer through mucus

580

Drug transfer through mucus

581

Drug transport in corneal epithelium and blood–retina barrier: Emerging role of transporters in ocular pharmacokinetics

582

Drug Transport Mechanism of Oral Antidiabetic Nanomedicines

583

Drug transport mechanisms and release kinetics from molecularly designed poly(acrylic acid-g-ethylene glycol) hydrogels

584

Drug transport proteins in the liver

585

Drug treatment behind bars: Prison-based strategies for change : By Kevin E. Early Praeger Publishers (P.O. Box 5007, Westport, Connecticut 06881-5007), 1996, 192 pp., hardcover—$55.00

586

Drug treatment for bleeding oesophageal varices

587

Drug treatment for Crohnʹs disease

588

Drug treatment of bothersome lower urinary tract symptoms after ureteric JJ-stent insertion: A contemporary, comparative, prospective, randomised placebo-controlled study, single-centre experience

589

Drug treatment of delirium: Past, present and future

590

Drug treatment of non-variceal upper gastrointestinal bleeding

591

Drug treatment of obesity

592

Drug Treatment of Patients with Liver Cirrhosis in a Tertiary Hospital in Northern Ghana: Does It Comply with Recommended Guidelines?

593

Drug treatment outcome methodology (1993–1997): Strengths, weaknesses, and a comparison to the alcohol field

594

Drug treatment-related factors of inadequate seizure control

595

Drug treatments for obesity

596

Drug treatments for obesity

597

Drug treatments for obesity

598

Drug treatments for obesity – Authorsʹ reply

599

Drug treatments for obesity: orlistat, sibutramine, and rimonabant

600

Drug treatments of levodopa-induced dyskinesias

601

Drug Use among Residents of Juvenile Correctional Center in Kerman, Iran, and its Relationship with Personality Dimensions and Self-concept

602

Drug use and abuse in sport

603

Drug use and drinking among students in 36 countries

604

Drug Use and High-Risk Sexual Behaviors of Women at a Drop-In Center in Mazandaran Province, Iran, 2014

605

Drug use and HIV/ AIDS in Burma

606

Drug Use and Sex Work Among At-risk Women: A Qualitative Study of Initial Factors

607

Drug use and the severity of a traffic accident

608

Drug use behaviors among asian drug users in san francisco

609

Drug use behaviour of pregnant women in rural India

610

Drug use during pregnancy

611

Drug use during pregnancy

612

Drug use during pregnancy: are risk classifications more dangerous than the drugs?

613

Drug use evaluation of antibiotics prescribed in a Jordanian Hospital outpatient and emergency clinics using WHO prescribing indicators

614

Drug use evaluation of antibiotics prescribed in a Jordanian hospital outpatient and emergency clinics using WHO prescribing indicators

615

Drug Use Evaluation of Crystalline Penicillin in Pediatrics Ward of Dessie Referral Hospital, North East Ethiopia: A Hospital Based Cross Sectional Study

616

Drug Use Evaluation of Human Intravenous Immunoglobulin (IVIG) in a Teaching Hospital in East of Iran

617

Drug Use for Secondary Prevention of Cardiovascular Diseases in Golestan, Iran: Results From the Golestan Cohort Study

618

Drug use is associated with elevated food consumption in college students

619

Drug Use Pattern Among Elderly People Referred to the Retirement Centers

620

Drug Use Patterns at Major Rock Concert Events

621

Drug usersʹ access to community-based services

622

Drug usersʹ brains to be removed 2 hours after death

623

Drug usersʹ sexual relationships and the social organisation of risk: The sexual relationship as a site of risk management

624

Drug utilisation and self-medication in rural communities in Vietnam

625

Drug utilization and nutrition patterns among children from indigent and emigrant families in Crete, Greece

626

Drug Utilization Evaluation of Agents Administered for Prevention and Treatment of Cancer-Related Infections

627

Drug Utilization Evaluation of Antibiotics in Burn Patients at a Referral Teaching Hospital

628

Drug Utilization Evaluation of Antibiotics in Intensive Care Units of a Referral Teaching Hospital

629

Drug Utilization Evaluation of Carbapenems in a Teaching Hospital in Tabriz-Iran

630

Drug Utilization Evaluation of Carbapenems in a Teaching Hospital in Tabriz-Iran

631

Drug Utilization Evaluation of Cefepime and Meropenem Based on the Infectious Disease Society of America and Defined Daily Dose Guidelines at the Payambare-Azam Bandar Abbas Hospital: A Retrospective Study

632

Drug Utilization Evaluation of Colistin: A Retrospective Study

633

Drug Utilization Evaluation of Imipenem and Intravenous Ciprofloxacin in a Teaching Hospital

634

Drug Utilization Evaluation of Imipenem in an Educational Hospital in Mazandaran Province

635

Drug Utilization Evaluation of Imipenem in Patients Undergoing Bone Marrow Transplantation

636

Drug utilization evaluation of meropenem: an important broad-spectrum antibiotic for the treatment of serious bacterial infections in hospitalized patients

637

Drug utilization evaluation of Rivaroxaban in both inpatient and outpatient settings: Using standard guidelines

638

Drug utilization evaluation of third generation cephalosporins using core drug use indicators

639

Drug Utilization Evaluation of Two Broad-Spectrum Antimicrobials: Cefepime and Piperacillin/Tazobactam in a Teaching Hospital in Tabriz, Iran

640

Drug Utilization Evaluation of Vancomycin in a Referral Infectious Center in Mazandaran Province

641

Drug Utilization Evaluation of Vancomycin in Pediatric Department

642

Drug utilization patterns in Rawalpindi and Islamabad, Pakistan

643

Drug Utilization Review of Conventional Amphotericin B in Febrile Neutropenic Patients Hospitalized at a Bone Marrow Transplant Center

644

Drug Utilization Review of Vancomycin in Febrile Neutropenic Patients Hospitalized at a Bone Marrow Transplantation Center

645

Drug Utilization Study on Acute Poisoning Cases Treated at a Tertiary Care Hospital in Western Part of India

646

Drug with potential to clear amyloid

647

Drug/device combinations for local drug therapies and infection prophylaxis

648

Drug-Coated Balloons for Infrapopliteal Disease: Digging Deep to Understand the Impact of a Negative Trial

649

Drug-company sponsorship and the Declaration of Helsinki

650

Drug-company sponsorship and the Declaration of Helsinki

651

Drug-delivering coronary artery stents: bare metal threatened by extinction?

652

Drug-Dependent Requirement of Hippocampal Neurogenesis in a Model of Depression and of Antidepressant Reversal

653

Drug–DNA interaction: A theoretical study on the binding of thionine with DNAs of varying base composition

654

Drug–DNA interactions and their study by UV–Visible, fluorescence spectroscopies and cyclic voltametry

655

Drug-drug and drug-disease interactions in the ED: Analysis of a high-risk population

656

Drug-drug co-crystals

657

Drug-Drug Interaction Extraction via Convolutional Neural Networks

658

Drug–drug interaction mediated by inhibition and induction of P-glycoprotein

659

Drug-Drug Interactions among Kidney Transplant Recipients in The Outpatient Setting

660

Drug‐Drug Interactions in Elderly Adults in Dentistry Care: a Cross-Sectional Study

661

Drug-drug interactions in inpatient and outpatient settings in Iran: a systematic review of the literature

662

Drug-Drug Interactions: Influence of verapamil on the pharmacokinetics of sitagliptin in rats and Ex vivo models

663

Drug‑drug Interactions: The Importance of Medication Reconciliation (Letters to the Editor Volume 6 - Issue 1 - January-March 2017 )

664

Drug-drug interation prediction between ketoconazole and anti-liver cancer drug Gomisin G

665

Drug-Drug/Drug-Excipient Compatibility Studies on Curcumin using Non-Thermal Methods

666

Drug-Drug-Induced Akathisia: Two Case Reports

667

Drug-efficacy depends on the inhibitor type and the target position in a metabolic network—A systematic study

668

Drug-eluted stent fracture occurred within 3 years lead to chronic total occlusion and aneurysm

669

Drug-eluting Balloon (DEB) for De-Novo Coronary Artery Disease and In-stent Restenosis: Immediate and Intermediate Term Results from a Prospective Registry

670

Drug-Eluting Balloon for Treatment of Superficial Femoral Artery In-Stent Restenosis

671

Drug-Eluting Balloon Versus Standard Balloon Angioplasty for Infrapopliteal Arterial Revascularization in Critical Limb Ischemia: 12-Month Results From the IN.PACT DEEP Randomized Trial

672

Drug-eluting bioabsorbable stents – An in vitro study

673

Drug-Eluting Compared With Bare-Metal Coronary Stents Among Elderly Patients Original Research Article

674

Drug-eluting stent fracture occurred within 2 days after stent implantation

675

Drug-Eluting Stent Fracture within 6 Days after Stent Implantation

676

Drug-Eluting Stent Fracture: Promise and Performance

677

Drug-Eluting Stent Implantation and Coronary Collateral Growth Attenuation: Is Drug the Only Culprit?

678

Drug-Eluting Stent Implantation May Not Affect Vasomotor Function in Early Phase

679

Drug-Eluting Stent Restenosis: The Pattern Predicts the Outcome Original Research Article

680

Drug-Eluting Stent Thrombosis: A Pooled Analysis

681

Drug-Eluting Stent Thrombosis: A Pooled Analysis: Reply

682

Drug-Eluting Stent Thrombosis: Increasingly Recognized But Too Frequently Overemphasized

683

Drug-eluting stent thrombosis: Results from a pooled analysis including 10 randomized studies Original Research Article

684

Drug-Eluting Stent Thrombosis: Results From the Multicenter Spanish Registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos) Original Research Article

685

Drug-Eluting Stent-Induced Left Anterior Descending Coronary Artery Aneurysm: Repair by Pericardial Patch—Where Are We Headed?

686

Drug-Eluting Stent-Induced Vascular Dysfunction: Common and Missing Links

687

Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients With Diabetes Mellitus: The DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy After Drug-Eluting Stent I

688

Drug-Eluting Stenting for Unprotected Left Main Coronary Artery Disease: Are We Ready to Replace Bypass Surgery?

689

Drug-Eluting stents

690

Drug-Eluting Stents “Next Generation” Basic Science Workshop

691

Drug-eluting stents 1— preclinical

692

Drug-eluting stents 2-economics and cost effectiveness

693

Drug-eluting stents 3-restenosis following stenting with drug-eluting stents

694

Drug-eluting stents 4-paclitaxel, everolimus, and other agents

695

Drug-eluting stents and glycoprotein IIb/IIIa inhibitors: Combination therapy for the future

696

Drug-Eluting Stents and Late Adverse Clinical Outcomes: Lessons Learned, Lessons Awaited

697

Drug-eluting stents and late stent thrombosis

698

Drug-Eluting Stents and the Future of Coronary Artery Bypass Surgery: Facts and Fiction

699

Drug-Eluting Stents Are Safe and Effective: Right or Wrong?

700

Drug-Eluting Stents for Acute Myocardial Infarction

701

Drug-eluting stents for coronary artery disease: A review

702

Drug-Eluting Stents for Critical Limb Ischemia

703

Drug-eluting stents for diabetes mellitus: A rush to judgment? Review Article

704

Drug-Eluting Stents for Saphenous Vein Graft Lesions: The Limits of Evidence

705

Drug-eluting stents for the treatment of bifurcation lesions: A randomized comparison between paclitaxel and sirolimus stents

706

Drug-eluting stents in diabetics & Complex patient groups

707

Drug-Eluting Stents in Heart Transplant Recipients

708

Drug-Eluting Stents in the Treatment of Intermediate Lesions: Pooled Analysis From Four Randomized Trials Original Research Article

709

Drug-eluting stents in total coronary occlusions: Another piece of the puzzle solved?

710

Drug-eluting stents in vascular intervention

711

Drug-Eluting Stents Versus Bare Metal Stents for Narrowing in Saphenous Vein Grafts

712

Drug-Eluting Stents Versus Bare Metal Stents in Percutaneous Coronary Interventions (A Meta-Analysis)

713

Drug-Eluting Stents Versus Bilateral Internal Thoracic Grafting for Multivessel Coronary Disease

714

Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Patients with Diabetes Mellitus

715

Drug-eluting stents vs bare metal stents for the treatment of large coronary vessels

716

Drug-eluting stents, 5-sirolimus stents and oral rapamycin

717

Drug-eluting stents: A multidisciplinary success story

718

Drug-eluting stents: an innovative multidisciplinary drug delivery platform

719

Drug-eluting stents: Beyond the hyperbole

720

Drug-eluting stents: Factors governing local pharmacokinetics

721

Drug-eluting stents: Failures and restenosis

722

Drug-eluting stents: insights into safety and indications

723

Drug-eluting stents: is new necessarily better?

724

Drug-Eluting Stents: Is Their Future as Bright as Their Past?

725

Drug-eluting stents: Lesion subsets

726

Drug-Eluting Stents: Life Insurance With a Better Death Benefit

727

Drug-eluting stents: Miscellaneous

728

Drug-eluting stents: Patient and lesion subsets

729

Drug-eluting stents: Registries and trials

730

Drug-eluting stents: Registries and trials

731

Drug-eluting stents: results, promises and problems

732

Drug-eluting stents: some bare facts

733

Drug-Eluting Versus Bare Metal Stents for Saphenous Vein Graft Intervention

734

Drug-evaluation harmonisation will lead to fewer animal tests

735

Drug-exposed infant cases in juvenile court: risk factors and court outcomes

736

Drug-Facilitated Effects on Protective Airway Reflexes During Out-of-Hospital Endotracheal Intubation

737

Drug-free in vitro activation and autologous transplantation in infertile women with diminished ovarian reserve: An experimental pilot study

738

Drugging Drug Resistance

739

Drugging the Bad “AKT-TOR” to Overcome TKI-Resistant Lung Cancer

740

Drugging the Undruggable

741

Drug–GSH interaction on GSH–Au modified electrodes: A cyclic voltammetry and electrochemical impedance spectroscopy study

742

Drug-hormone interactions on neurobehavioral responses in human neonates

743

Drug-induced Acute Interstitial Nephritis Pathology, Pathogenesis, and Treatment

744

Drug-induced amnesia impairs implicit relational memory

745

Drug-induced and toxic myopathies

746

Drug-Induced Apnea in Children Admitted to Loghman Hakim Hospital, Tehran, Iran

747

Drug-induced atrial fibrillation Review Article

748

Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug Original Research Article

749

Drug-induced autoimmunity

750

Drug-Induced Brugada Syndrome in Children: Clinical Features, Device-Based Management, and Long-Term Follow-Up

751

Drug-Induced Bullous Pemphigoid: Rapid Resolution with Corticosteroid Therapy

752

Drug-Induced by Systemic Lupus Erythematosus Presenting as Recurrent Pericardial Effusion After Mitral Valve Repair

753

Drug-induced cholestasis

754

Drug-induced gingival overgrowth and its tentative pharmacotherapy

755

Drug-Induced Gingival Overgrowth in an 8-Year-Old Girl: A Case Report

756

Drug-induced headaches

757

Drug-induced headaches

758

Drug-induced heart failure

759

drug-induced hemophagocytosis

760

Drug-induced hepatocellular liver injury due to benzylpenicillin with evidence of lymphocyte sensitization

761

Drug-induced hyperkalemia

762

Drug-induced hyperkalemia: old culprits and new offenders

763

Drug-induced hyperkalemia: The reply:

764

Drug-Induced Hypersensitivity Syndrome (DRESS) by Phenobarbital - Case Report and Literature Review

765

Drug-Induced Hypersensitivity Syndrome Caused by Carbamazepine Used for the Treatment of Trigeminal Neuralgia

766

Drug-induced interstitial nephritis in a child with idiopathic nephrotic syndrome

767

Drug-Induced Lichen Planus

768

Drug-Induced Linear Immunoglobulin-A Bullous Dermatosis

769

Drug-induced liver diseases

770

Drug-induced liver injury following positive drug rechallenge

771

Drug-Induced Long QT Syndrome and Exome Sequencing: Chinese Shadows Link Past and Future

772

Drug-induced lupus erythematosus

773

Drug-Induced Lupus Erythematosus

774

Drug-induced methemoglobinemia during thoracoscopic lung biopsy

775

Drug-induced myocardial infarction in young patients: Report of two cases

776

Drug-induced Nephrotoxicity and Medicinal Plants

777

Drug-induced neurological disorders : by K.K. Jain, 1996, Hogrefe & Huber Publishers, Seattle, USA, 389 pages, US$ 79, ISBN 0-88937-154-7

778

Drug-Induced Pemphigoid:: Bullous and Cicatricial

779

Drug-Induced Pemphigus

780

Drug-induced QT interval prolongation after ciprofloxacin administration in a patient receiving olanzapine

781

Drug-Induced QT Interval Prolongation and Torsade De Pointes:Identification of Risk Factors

782

Drug-induced renal disorders

783

Drug-Induced Scleroderma and Sclerodermiform Conditions

784

Drug-induced stabilisation of a mismatched C-T base pair in a DNA hairpin

785

Drug-induced systemic lupus erythematosus and TNF-α blockers

786

Drug-induced systemic lupus erythematosus and TNF-α blockers

787

Drug-induced systemic lupus erythematosus and TNF-α blockers

788

Drug-induced systemic lupus erythematosus associated with etanercept therapy

789

Drug-induced torsades de pointes in one patient with congenital long QT syndrome

790

Drug-Induced Toxic Epidermal Necrolysis

791

Drug-induced tremors

792

DRUG-INDUCED VASCULITIS IN A BREAST CANCER PATIENT RECEIVING CHEMOTHERAPY

793

Drug–lactose binding aspects in adhesive mixtures: Controlling performance in dry powder inhaler formulations by altering lactose carrier surfaces

794

Drug-licensing anomalies and Parkinsonʹs disease

795

Drug-loaded chondroitin sulfate-based nanogels: Preparation and characterization

796

Drug-loaded electrospun nanofibrous sheets as barriers against postsurgical adhesions in mice model

797

Drug-loaded polyelectrolyte microcapsules for sustained targeting of cancer cells

798

Drug-lunch alert

799

Drugmaker seeks permissions to collaborate on Cuban vaccine

800

Drug–protein interactions assessed by fluorescence measurements in the real complexes and in model dyads

801

Drug-related Death low Registration in Iran: A Mixed Method Approach for Causes, Recommendations to Solve This Problem and Geographical Evaluation of an Intervention

802

Drug-related deaths by region, sex, and age group per 100 injecting drug users in Scotland, 2000–01

803

Drug-related killings: a case of mistaken identity Review Article

804

Drug-related problems (DRPs) identified from geriatric medication safety review clinics

805

Drug-related Problems Among Type 2 Diabetic Patients With Hypertension in a Tertiary Care Hospital in Lebanon: A Cross-sectional Study

806

Drug‑related Problems in Hypertensive Patients: A Cross‑sectional Study from Indonesia

807

Drug-related Problems in Solid-Organ Transplant Recipients Hospitalized for COVID-19: An Experience of a Referral Tertiary Center in Iran

808

Drug-Resistance Associated Mutations in Polymerase (P) Gene of Hepatitis B Virus Isolated From Malaysian HBV Carriers

809

Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial

810

Drug-resistant enteric fever in the UK

811

Drug-resistant epilepsy and epileptic phenotype-EEG association in MECP2 mutated Rett syndrome

812

Drug-resistant genotyping in HIV-1 therapy

813

Drug-resistant genotyping in HIV-1 therapy

814

Drug-resistant genotyping in HIV-1 therapy

815

Drug-resistant genotyping in HIV-1 therapy

816

Drug-resistant genotyping in HIV-1 therapy

817

Drug-resistant gonorrhoeae spread in the USA

818

Drug-Resistant Phosphatidylinositol 3-Kinase: Guidance for the Preemptive Strike

819

Drug-resistant Pneumocystis carinii

820

Drug-Resistant Proteus Virulence Factors Characterization and Their Inhibition Using Probiotic Bacteria

821

Drug-resistant pulmonary tuberculosis in western Turkey : Prevalence, clinical characteristics and treatment outcome

822

Drug-resistant strains of HIV increase sharply in Japan

823

Drug-resistant Streptococcus pneumoniae: rational antibiotic choices

824

Drug-resistant tuberculosis

825

Drug-Resistant Tuberculosis and Group 5 Anti-Tuberculosis Drugs

826

Drug-resistant tuberculosis in Taipei, 1996-1999

827

Drug-resistant tuberculosis: desperate measures?

828

Drugs & devices in brief

829

Drugs against superbugs: private lessons from bacteriophages

830

Drugs and a dark future

831

Drugs and Addictive Behaviour: A Guide to Treatment (3rd edition): Hamid Ghodse, Cambridge University Press 2002. £39.95, 520 pages

832

Drugs and demons

833

Drugs and mental health

834

Drugs and narcotics in history : Edited by Roy Porter and Mikulas Teich. Cambridge University Press, Cambridge, 1995. xii + 227 pp., U.S.$49.95 (cloth)

835

Drugs and nutrition: how side effects can influence nutritional intake

836

Drugs and nutrition: Important drug-nutrient interactions

837

Drugs and personal care products as ubiquitous pollutants: occurrence and distribution of clofibric acid, caffeine and DEET in the North Sea

838

Drugs and pests: intertemporal production externalities

839

Drugs and Pharmacology for Nurses, 12th edn, S.J. Hopkins. Churchill Livingstone (1995), ISBN: 0-443-05249-2

840

Drugs and risk-taking in tourism

841

Drugs and the art of Fred Tomaselli

842

Drugs and the immune system: the emerging era of immunopharmacology

843

Drugs deaths drop in Switzerland

844

Drugs elevating extracellular adenosine enhance cell cycling of hematopoietic progenitor cells as inferred from the cytotoxic effects of 5-fluorouracil

845

Drugs Expiration Date Dilemma!

846

Drugs for Left Ventricular Remodeling in Heart Failure

847

Drugs for obstetric conditions

848

Drugs for the gynecologist to prescribe in the prevention of breast cancer: Current status and future trends

849

Drugs for vascular dementia

850

Drugs in Exacerbation and Provocation of Psoriasis

851

Drugs in Nursing Practice: C R Henney, RJ Dow, A M Macconnachie Churchill Livingstone, 1995, 5th edn ISBN 0-443-05235-2, 482 pages Price £12.95

852

Drugs in Pregnancy and Lactation, Sixth Edition: Gerald G. Briggs, Roger K. Freeman, & Sumner J.Yaffe. ISBN 0-7817-3203-4, Lippincott Williams & Wilkins, Philadelphia, 2002, 1595 pp

853

Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources – a review

854

Drugs in the Plant

855

Drugs in the postgenomic era

856

Drugs Induced Alzheimer’s Disease in Animal Model

857

Drugs lose out to revascularisation in symptom-free coronary disease

858

DRUGS MINIMIZING BLOOD LOSS DURING LIVER TRANSPLANTATION

859

Drugs of Abuse and Alcohol in Weekend Drivers Involved in Car Crashes in Belgium, , ,

860

Drugs of Abuse and Immuno-Modulation

861

Drugs of abuse and reward comparison: a brief review

862

Drugs of abuse and the elicitation of human aggressive behavior

863

Drugs of abuse in oral fluid collected by two different sample kits – Stability testing and validation using ultra performance tandem mass spectrometry analysis

864

Drugs of abuse in pregnancy

865

Drugs of abuse in urban groundwater. A case study: Barcelona Original Research Article

866

Drugs or Implantable Cardioverter-Defibrillators in Patients with Poor Left Ventricular Function?

867

Drugs Prescribed by Dentists in Fars Province, Iran

868

Drugs solubilization in ascorbyl–decanoate micellar solutions

869

870

Drugs Used in Pregnancy

871

Drugs used in the treatment of attention-deficit/hyperactivity disorder affect postsynaptic firing rate and oscillation without preferential dopamine autoreceptor action

872

Drugs, diet and disease

873

Drugs, HIV Treatment and Harm Reduction Services for Afghan Refugees in Iran

874

Drugs, leads, and drug-likeness: an analysis of some recently launched drugs

875

DRUGS-FACILITATED STREET AND TRAVEL RELATED CRIMES: A NEW PUBLIC HEALTH ISSUE

876

Drug-testing practices in US hotels

877

Drug-trial “irregularities” uncovered in Argentina

878

Drug-trial compensation demands in lreland

879

Drug-use behavior and correlates in people with schizophrenia

880

Drug-use initiation and conduct disorder among adolescents in drug treatment

881

Druid wins Baan contract with Weston Aerospace

882

Drum agglomeration behavior of nickel laterite ore: Effect of process variables

883

Drum granulation of NPK fertilizers

884

Drum leaching tests in iron removal from quartz using oxalic and sulphuric acids

885

Drum Sound Recognition for Polyphonic Audio Signals by Adaptation and Matching of Spectrogram Templates With Harmonic Structure Suppression

886

Drum-boiler dynamics

887

Drum-like silencers using magnetic forces in a pressurized cavity

888

889

Drunk drivers in the courts: Legal and extra-legal factors affecting pleas and sentences

890

Drunk driving and mental disorders

891

Drunk driving and mental disorders

892

Drunk, but not blind: The effects of alcohol intoxication on change blindness

893

Drupangtonine, a novel antileukemic alkaloid from Cephalotaxus harringtonia var. drupacea

894

Drushbametrics — My Russian adventures

895

Dry aging of beef in a bag highly permeable to water vapour

896

Dry air effects on the copper oxides sensitive layers formation for ethanol vapor detection

897

Dry anaerobic digestion of food waste under mesophilic conditions: Performance and methanogenic community analysis

898

Dry and lubricated wear resistance of mechanically-alloyed aluminium-base sintered composites

899

Dry and semi-dry machining using finely crystallized diamond coating cutting tools

900

Dry and Wet Abrasive Conditions of Fe-C-B Wear Resistance Hardfacing Alloy on Mild Steel

901

Dry and wet abrasive resistance of Inconel 600 and stellite

902

Dry and wet atmospheric deposition of nitrogen and phosphorus in Singapore

903

Dry and wet deposition of elemental carbon on a tropical forest in Thailand

904

Dry and wet deposition of elements in Hong Kong

905

Dry and wet deposition of mercury near a chlor-alkali plant

906

Dry and wet deposition of nutrients from the tropical Atlantic atmosphere: Links to primary productivity and nitrogen fixation

907

Dry and wet deposition of water-insoluble dust and water-soluble chemical species during spring 2007 in Tsukuba, Japan

908

Dry and wet rainy seasons in the Mantaro river basin (Central Peruvian Andes)

909

Dry and wet sliding wear of ITO-coated PET components used in flexible optoelectronic applications

910

Dry and Wet Wear Characteristic of TiO2 Thin Film Prepared by Magnetic Sputtering in Ringer Solution

911

Dry ashing of organic rich matrices with palladium for the determination of arsenic using inductively coupled plasma-mass spectrometry Original Research Article

912

Dry atmospheric deposition and deposition velocities of dicamba, 2,4-dichlorophenoxyacetic acid and γ-1,2,3,4,5,6-hexachlorocyclohexane Original Research Article

913

Dry atmospheric deposition and diazotrophy as sources of new nitrogen to northwestern Mediterranean oligotrophic surface waters

914

Dry atmospheric deposition rates of metals along a coastal transect in southern California

915

Dry atmospheric fluxes of trace metals (Al, Fe, Mn, Pb, Cd, Zn, Cu) over the Levantine Basin: A refined assessment

916

Dry atmospheric inputs of trace metals at the Mediterranean coast of Israel (SE Mediterranean): sources and fluxes

917

Dry bag isostatic pressing for improved green strength of surrogate nuclear fuel pellets

918

Dry Bean Intake of Women Ages 19-45

919

Dry Bean Production in Zero and Conventional Tillage

920

Dry beneficiation of Slovakian coal

921

Dry beneficiation technology of coal with an air dense-medium fluidized bed

922

Dry boards as load bearing element in the profiled steel sheet dry board floor panel system—structural performance and applications

923

Dry catalyst impregnation in a double cone blender: A computational and experimental analysis

924

Dry catalytic partial oxidation of diesel–fuel distillates into syngas

925

Dry citrate-precursor synthesized nanocrystalline cobalt oxide as highly active catalyst for total oxidation of propane

926

Dry cleaning for metallic contaminants removal as the second cleaning process after the CMP process

927

Dry cleaning of metal surfaces by a vacuum arc

928

Dry climate near the Western Pacific Warm Pool: Pleistocene caliches of the Nansha Islands, South China Sea

929

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

930

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

931

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

932

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

933

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

934

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

935

Dry coating of talc particles with fumed silica: Influence of the silica concentration on the wettability and dispersibility of the composite particles

936

Dry coating polymer powder particles with deagglomerated carbon nanotubes to improve their dispersion in nanocomposites

937

Dry coatings and ecodesign part. 1 — Environmental performances and chemical properties

938

Dry coatings and ecodesign: Part. 2 — Tribological performances

939

Dry cooling towers as condensers for geothermal power plants

940

Dry cooling with night cool storage to enhance solar power plants performance in extreme conditions areas

941

Dry cupping therapy and the wellness management of health travelers

942

Dry cutting performance of partially filtered arc deposited titanium aluminium nitride coatings with various metal nitride base coatings

943

Dry deep drawability of A5052 aluminum alloy sheet with DLC-coating

944

Dry degumming of vegetable oils by membrane filtration Original Research Article

945

Dry dense medium separation of iron ore using a gas–solid fluidized bed

946

Dry densification of carbon nanotube bundles Original Research Article

947

Dry deposition (downward, upward) concentration study of particulates and heavy metals during daytime, nighttime period at the traffic sampling site of Sha-Lu, Taiwan

948

Dry deposition and concentration of marine aerosols in a coastal area, SW Sweden

949

Dry deposition and foliar leaching of mercury and selected trace elements in deciduous forest throughfall

950

Dry deposition and interception of 4–22 μm diameter particles to a lettuce crop

951

Dry deposition and internal circulation of nitrogen, sulphur and base cations to a coniferous forest

952

Dry deposition and particle-size distribution of phosphorus in the marine atmosphere over the northeastern coast of Taiwan

953

Dry deposition and particle-size distributions of polycyclic aromatic hydrocarbons in the ambient air of a petrochemical plant

954

Dry deposition and resuspension of particle-associated metals near a freeway in Los Angeles

955

Dry deposition and soil–air gas exchange of polychlorinated biphenyls (PCBs) in an industrial area

956

Dry deposition calculations for the clean air status and trends network

957

Dry deposition effect of marine aerosol to the building stone of the medieval city of Rhodes, Greece

958

Dry deposition fluxes and atmospheric size distributions of mass, al, and mg measured in southern Lake Michigan during aeolos

959

Dry deposition fluxes and deposition velocities of PAHs at an urban site in Turkey

960

Dry deposition fluxes and velocities of polychlorinated biphenyls (PCBs) associated with particles

961

Dry deposition fluxes of ambient particulate heavy metals in a small city, Korea

962

Dry deposition measured with a water surface sampler: a comparison to modeled results

963

Dry deposition model for atmospheric particles

964

Dry deposition modelling of atmospheric aerosols from a lead smelting industry

965

Dry deposition of 214Pb to conifers

966

Dry deposition of acidic air pollutants to tree leaves, determined by a modified leaf-washing technique

967

Dry deposition of aerosol particles within model spruce canopies

968

Dry deposition of ammonia, nitric acid, ammonium, and nitrate to alpine tundra at Niwot Ridge, Colorado

969

Dry deposition of atmospheric polycyclic aromatic hydrocarbons (PAHs) in the southeast suburb of Beijing, China

970

Dry deposition of electrically charged aerosols

971

Dry deposition of gaseous elemental mercury to plants and soils using mercury stable isotopes in a controlled environment

972

Dry deposition of gaseous oxidized mercury in Western Maryland Original Research Article

973

Dry deposition of gaseous radioiodine and particulate radiocaesium onto leafy vegetables Original Research Article

974

Dry deposition of large, airborne particles onto a surrogate surface

975

Dry Deposition of Nonspherical Particles on Natural and Surrogate Surfaces

976

Dry deposition of ozone on building materials. Chamber measurements and modelling of the time-dependent deposition

977

Dry deposition of particles and canopy exchange: Comparison of wet, bulk and throughfall deposition at five forest sites in Italy

978

Dry deposition of particles in a coastal forest

979

Dry deposition of particles to building surfaces and soiling

980

Dry deposition of particles to wave surfaces: I. Mathematical modeling

981

Dry deposition of particles to wave surfaces: II. Wind tunnel experiments

982

Dry deposition of polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/Fs) in ambient air

983

Dry deposition of polycyclic aromatic hydrocarbons in urban and rural sites of Western Greece

984

Dry deposition of reactive nitrogen to marine environments: recent advances and remaining uncertainties

985

Dry Deposition of SO2 Over Dry Dipterocarp Forest, Thailand

986

Dry deposition of sulfate-containing particulate at the highway intersection, coastal and suburban areas

987

Dry deposition of sulphate and nitrate to polypropylene surfaces in a semi-arid area of India

988

Dry deposition of sulphur dioxide and ammonia on wet surfaces and the surface oxidation kinetics of bisulphite

989

Dry deposition of sulphur over eastern South Africa

990

Dry deposition profile of small particles within a model spruce canopy

991

Dry deposition to forests—On the use of data from clearings

992

Dry deposition to pine of sulphur dioxide and ozone at low concentration

993

Dry deposition velocity of PM2.5 ammonium sulfate particles to a Norway spruce forest on the basis of S- and N-balance estimations

994

Dry deposition velocity of sulfur dioxide over rice paddy in the tropical region

995

Dry deposition washoff and dew on the surfaces of pine foliage on the urban- and mountain-facing sides of Mt. Gokurakuji, western Japan

996

Dry deposition, concentration and gas/particle partitioning of atmospheric carbazole

997

Dry deposition, ionic species measured and source interpretation during seasonal cycle at offshore areas near Taiwan Strait

998

Dry deposition, seasonal variation and source interpretation of ionic species at Abali, Firouzkouh and Varamin, Tehran Province, Iran

999

Dry dilute acid pretreatment by co-currently feeding of corn stover feedstock and dilute acid solution without impregnation

1000

Dry dispersion of fine particles in gaseous phase

بازگشت